CCMW
TVRD
Cypress Capital Management (Wyoming)’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,000
| Closed | -$1.54K | – | 166 |
|
|
2024
Q3 | $1.54K | Hold |
5,000
| – | – | ﹤0.01% | 141 |
|
|
2024
Q2 | $1.29K | Hold |
5,000
| – | – | ﹤0.01% | 146 |
|
|
2024
Q1 | $4.55K | Sell |
5,000
-350
| -7% | -$319 | ﹤0.01% | 125 |
|
|
2023
Q4 | $3.98K | Hold |
5,350
| – | – | ﹤0.01% | 125 |
|
|
2023
Q3 | $8.99K | Hold |
5,350
| – | – | 0.01% | 113 |
|
|
2023
Q2 | $15.1K | Hold |
5,350
| – | – | 0.02% | 90 |
|
|
2023
Q1 | $26.3K | Hold |
5,350
| – | – | 0.03% | 83 |
|
|
2022
Q4 | $57.5K | Sell |
5,350
-2,095
| -28% | -$22.5K | 0.07% | 67 |
|
|
2022
Q3 | $70K | Sell |
7,445
-8,595
| -54% | -$80.8K | 0.1% | 60 |
|
|
2022
Q2 | $146K | Hold |
16,040
| – | – | 0.19% | 45 |
|
|
2022
Q1 | $195K | Sell |
16,040
-603
| -4% | -$7.33K | 0.23% | 45 |
|
|
2021
Q4 | $203K | Buy |
+16,643
| New | +$203K | 0.17% | 71 |
|
|
2021
Q3 | – | Sell |
-16,743
| Closed | -$239K | – | 319 |
|
|
2021
Q2 | $239K | Sell |
16,743
-55,572
| -77% | -$793K | 0.18% | 75 |
|
|
2021
Q1 | $1.57M | Sell |
72,315
-8,954
| -11% | -$194K | 1.38% | 27 |
|
|
2020
Q4 | $1.23M | Sell |
81,269
-97,928
| -55% | -$1.48M | 1.06% | 32 |
|
|
2020
Q3 | $2.51M | Sell |
179,197
-723
| -0.4% | -$10.1K | 2.25% | 12 |
|
|
2020
Q2 | $3.08M | Sell |
179,920
-34
| -0% | -$581 | 3.07% | 7 |
|
|
2020
Q1 | $2.38M | Sell |
179,954
-4,131
| -2% | -$54.6K | 3.35% | 7 |
|
|
2019
Q4 | $2.97M | Buy |
+184,085
| New | +$2.97M | 2.8% | 7 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 265 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 291 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 360 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 390 |
|
|
2018
Q3 | – | Sell |
-74,445
| Closed | -$1.43M | – | 372 |
|
|
2018
Q2 | $1.43M | Buy |
+74,445
| New | +$1.43M | 1.5% | 19 |
|